{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:15:41Z","timestamp":1756383341131},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,1,18]],"date-time":"2009-01-18T00:00:00Z","timestamp":1232236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00105-008-1682-0","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T15:01:17Z","timestamp":1232118077000},"page":"743-748","source":"Crossref","is-referenced-by-count":3,"title":["Erfolgreiche Therapie des Pemphigus foliaceus mit Rituximab","Successful treatment of pemphigus foliaceus with rituximab"],"prefix":"10.1007","volume":"60","author":[{"given":"M.","family":"Alter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,18]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","volume":"355","author":"Ahmed","year":"2006","unstructured":"Ahmed A, Spiegelman ZCL, Posner M (2006) Treatment of pemphigus vulgaris with rituximab and intravenous immunglobulin. N Engl J Med 355:1772\u20131779","journal-title":"N Engl J Med"},{"key":"1682_CR2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","volume":"153","author":"Arin","year":"2005","unstructured":"Arin MJ, Engert A, Krieg T, Hunzelmann N (2005) Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 153:620\u2013625","journal-title":"Br J Dermatol"},{"key":"1682_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","volume":"143","author":"Cianchini","year":"2007","unstructured":"Cianchini G, Corona R, Frezzolini A et al (2007) Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch Dermatol 143:1033\u20131038","journal-title":"Arch Dermatol"},{"key":"1682_CR4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-4632.2006.03007.x","volume":"45","author":"Fatourechi","year":"2006","unstructured":"Fatourechi MM, el Azhary RA, Gibson LE (2006) Rituximab: applications in dermatology. Int J Dermatol 45:1143\u20131155","journal-title":"Int J Dermatol"},{"key":"1682_CR5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2133.2003.05580.x","volume":"149","author":"Goebeler","year":"2003","unstructured":"Goebeler M, Herzog S, Broecker EB, Zillikens D (2003) Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol 149:899\u2013901","journal-title":"Br J Dermatol"},{"key":"1682_CR6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","volume":"156","author":"Goh","year":"2007","unstructured":"Goh M, McCormack C, Dinh H et al (2007) Rituximab in adjuvant treatment of peemphigus vulgaris: a prospective open-label pilot study in five patients. Br J Dermatol 156:990\u2013996","journal-title":"Br J Dermatol"},{"key":"1682_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","volume":"6","author":"Hertl","year":"2008","unstructured":"Hertl M, Zillikens D, Borradori L et al (2008) Empfehlungen f\u00fcr den Einsatz von Rituximab (anti-CD-20-Antik\u00f6rper) bei bull\u00f6sen Autoimmundermatosen. JDDG 6:366\u2013374","journal-title":"JDDG"},{"key":"1682_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","volume":"357","author":"Joly","year":"2007","unstructured":"Joly P, Mouquet H, Roujeau JC et al (2007) A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 357:545\u2013552","journal-title":"N Engl J Med"},{"key":"1682_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00105-007-1284-2","volume":"58","author":"Kasperkiewicz","year":"2007","unstructured":"Kasperkiewicz M, Zillikens D (2007) Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases. Hautarzt 58:115\u2013121","journal-title":"Hautarzt"},{"key":"1682_CR10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000099591","volume":"214","author":"Marzano","year":"2007","unstructured":"Marzano AV, Fanoni D, Venegoni L et al (2007) Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab). Dermatology 214:310\u2013318","journal-title":"Dermatology"},{"key":"1682_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"Reff","year":"1994","unstructured":"Reff ME, Carner K, Chambers KS et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435\u2013445","journal-title":"Blood"},{"key":"1682_CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","volume":"31","author":"Schmidt","year":"2006","unstructured":"Schmidt E, Hunzelmann N, Zillikens D et al (2006) Rituximab in autoimmune diseases. Clin Exp Dermatol 31:503\u2013508","journal-title":"Clin Exp Dermatol"},{"key":"1682_CR13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","volume":"158","author":"Shimanovich","year":"2008","unstructured":"Shimanovich I, Nitschke M, Rose C et al (2008) Treatment of severe pemphigus with protein A immunoadsorbtion, rituximab and intravenous immunoglobulins. Br J Dermatol 158:382\u2013388","journal-title":"Br J Dermatol"},{"key":"1682_CR14","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","volume":"125","author":"Stashenko","year":"1980","unstructured":"Stashenko P, Nadler LM, Hardy R, Schlossman SF (1980) Characterization of a human B lymphocyte-specific antigen. J Immunol 125:1678\u20131685","journal-title":"J Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1682-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1682-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:45:54Z","timestamp":1684860354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1682-0"}},"subtitle":["Bericht \u00fcber 3\u00a0Patienten","Report of 3 cases"],"short-title":[],"issued":{"date-parts":[[2009,1,18]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1682-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,18]]}}}